VALEAS SPA has a total of 26 patent applications. Its first patent ever was published in 1981. It filed its patents most often in EPO (European Patent Office), Canada and Italy. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ADORX THERAPEUTICS LTD, AUTOPHAGYSCIENCES INC and NOCION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 4 | |
#3 | Italy | 4 | |
#4 | United States | 4 | |
#5 | Australia | 3 | |
#6 | South Africa | 2 | |
#7 | Denmark | 1 | |
#8 | Ireland | 1 | |
#9 | New Zealand | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bernareggi Virgilio | 20 |
#2 | Fano Maurizio | 20 |
#3 | Bonifacio Fausto | 15 |
#4 | Margutti Roberto | 11 |
#5 | Gagnoni Alessandro | 5 |
#6 | Bonifacio F | 4 |
#7 | Trabella Luciano | 4 |
#8 | Fano M | 4 |
#9 | Montagna Davide | 4 |
#10 | Battigelli Giandomenico | 3 |
Publication | Filing date | Title |
---|---|---|
CA2149766A1 | Rectal flunisolide compositions for treating inflammatory intestinal disorders | |
EP0384450A1 | Tetrazole amide derivatives of heterocyclic alkenyl acids and their use as antiallergic substances | |
IE900631L | Pavement markings | |
EP0261503A1 | Heterocyclic amido derivatives of substituted benzoic acids and therapeutic compositions which contain them as active principle | |
IT8519367D0 | Terlipressine prepn. | |
EP0133218A2 | Endo-8,8-dialkyl-8-azoniabicyclo (3.2.1) octane-6,7-exo-epoxy-3-alkyl-carboxylate salts, a process for their preparation, and therapeutic compositions which contain them as active principle | |
US4411902A | Salts of endo-8-methyl-8-syn-alkyl-8-azoniabicyclo-[3.2.1]-octane-3-alkylcarboxylates, and therapeutic compositions containing them |